Monograph Details

Urogenital System > Miscellaneous urogenital disorders
K-PHOS #2
Manufacturer
Beach Pharmaceuticals
Legal Classification
Rx
Pharmacological Class
Urinary acidifier.
Generic Name
Potassium acid phosphate 305mg, sodium acid phosphate 700mg; equiv. to potassium 2.3mEq and sodium 5.8mEq; tabs.
Also
K-PHOS M.F.
K-PHOS ORIGINAL
Indications
Urinary acidification.
Children
Not recommended.
Adults
1 tab 4 times a day with a full glass of water. If urine very alkaline, 1 tab every 2 hours; max 8 tabs daily.
Contraindications
Renal or adrenal insufficiency. Severe hepatic disease. Infected phosphate stones. Hyperphosphatemia. Hyperkalemia (Original).
Precautions
Electrolyte restrictions. Cardiac disease. Hypertension. Edema. Monitor serum electrolytes and for GI obstruction. Discontinue if laxation persists after dosage reduction. Hypoparathyroidism. Osteomalacia. Pancreatitis. Dehydration. Toxemia of pregnancy. Pregnancy (Cat.C). Nursing mothers.
Interactions
Antagonized by antacids. Hyperkalemia with ACE inhibitors, triamterene, spironolactone, amiloride, potassium supplements. Toxicity with digitalis. Hypernatremia with methyldopa, guanethidine, other antihypertensives, corticotropins, mineralocorticoids.
Adverse Reactions
Small bowel lesions, laxation, headache, dizziness, hyperacidity, nausea, weakness, confusion, paresthesias, seizures, arrhythmias, shortness of breath, edema.
How Supplied
Tabs—100